1-15 of 15
Nadira Durakovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party

Maria Carmen Martinez Munoz, Mariana Bastos-Oreiro, Ariane Boumendil, Hervé Finel, Ali Bazarbachi, Mohsen Alzahrani, Arpad Illes, Didier Blaise, Ioanna Sakellar, Carlos Solano, Alessandro Pulsoni, Tsila Zuckerman, Nadira Durakovic, Luca Castagna, Simona Sica, Stéphanie Guidez, Jean-Henri Bourhis, Ramón García-Sanz, Muhlis Cemm Ar, Aspasia Stamatoulas Bastard, Javier Briones, Saad Aktar, Ron Ram, Inmaculada Heras, Marie Thérèse Rubio, Mario Petrini, Mario Ojeda-Uribe, Bertram Glass, Anna Sureda
Journal: Blood
Blood (2022) 140 (Supplement 1): 6558–6560.
https://doi.org/10.1182/blood-2022-167644
Published: 2022
Journal Articles

Use of G-CSF for Bone Marrow Graft Mobilization Increases NK Cell, Treg and iNKT Cell Graft Content, Possibly Lowering the Risk of Severe Acute Gvhd and Chronic Gvhd in HLA-Haploidentical Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PT-CY)

Nadira Durakovic, Antonija Babić, Lana Desnica, Zinaida Peric, Ranka Serventi Seiwerth, Drago Batinić, Radovan Vrhovac
Journal: Blood
Blood (2022) 140 (Supplement 1): 7558–7559.
https://doi.org/10.1182/blood-2022-165445
Published: 2022
Journal Articles

Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study

Zrinka Sertić, Marko Lucijanic, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Bozena Coha, Drazen Pulanic, Dragana Šegulja, Dunja Rogić, Toni Valkovic, Igor Aurer, Nadira Durakovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 47.
https://doi.org/10.1182/blood-2021-153573
Published: 2021
Journal Articles

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Nikesh Dhiraj Chavda, MBBChir, Stephen Robinson, MBBS, PhD BSc, Ariane Boumendil, Irma Khvedelidze, Hervé Finel, Saad Akhtar, MD, M S Rauf, MD, Nadira Durakovic, MD, Radovan Vrhovac, MD PhD, Maurizio Musso, MD, Pauline Brice, Mutlu Arat, MD, Didier Blaise, MD PhD, Matthew P. Collin, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Aspasia Stamatoullas, MD, Zubeyde Nur Ozkurt, MD, Tadeusz Robak, MD, Björn E Wahlin, MD PhD, Keith Wilson, FRCPath, MRCP, MBBS, Eleonora Alma, Rocco Pastano, Luca Castagna, MD, Ali Bazarbachi, MD PhD, Hervé Ghesquieres, MD PhD, Andrei Colita, MD PhD, Silvia Montoto, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4018.
https://doi.org/10.1182/blood-2019-131410
Published: 2019
Journal Articles

Severe Ocular Graft-Versus-Host Disease Successfully Treated with Amniotic Membrane Transplantation - Case Series

Zinaida Peric, MD PhD, Ivan Skegro, MD, Nadira Durakovic, MD, Lana Desnica, MD PhD, Ranka Serventi-Seiwerth, MD, Drazen Pulanic, MD PhD, Igor Petricek, MD PhD, Steven Z. Pavletic, MD, Radovan Vrhovac, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3270.
https://doi.org/10.1182/blood.V130.Suppl_1.3270.3270
Published: 2017
Journal Articles

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Brief Report
Christopher G. Kanakry, Javier Bolaños-Meade, Yvette L. Kasamon, Marianna Zahurak, Nadira Durakovic, Terry Furlong, Marco Mielcarek, Marta Medeot, Ivana Gojo, B. Douglas Smith, Jennifer A. Kanakry, Ivan M. Borrello, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, William H. Matsui, Lode J. Swinnen, Kenneth R. Cooke, Richard F. Ambinder, Ephraim J. Fuchs, Marcos J. de Lima, Borje S. Andersson, Ravi Varadhan, Paul V. O’Donnell, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2017) 129 (10): 1389–1393.
https://doi.org/10.1182/blood-2016-09-737825
Published: 2017
Includes: Supplemental data
Journal Articles

Salvage Use of Ibrutinib after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for B Cell Malignancies: A Study of the French Cooperative Group for CLL, the French Soceity for Blood and Marrow Transplantation (SFGM-TC), and the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancy and Lymphoma Working Parties

Mauricette Michallet, MD PhD, Peter Dreger, MD, Mohamad Sobh, PharmD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Lutz Muller, MD, Paolo Corradini, MD, Wolfgang Bethge, MD, Domenico Russo, MD, Nadira Durakovic, MD PhD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD, Nicolaus Kroger, MD PhD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4659.
https://doi.org/10.1182/blood.V128.22.4659.4659
Published: 2016
Journal Articles

Ibrutinib for Bridging to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Is Safe and Effective: First Results of a Survey By the Chronic Malignancy and the Lymphoma Working Parties of the EBMT

Peter Dreger, MD, Mauricette Michallet, MD PhD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Mohamad Sobh, PharmD, Lutz Muller, MD, Elisabeth A. Vandenberghe, MB, MRCPI, MRCPath, PhD, Ilaria Scortechini, MD, Niels S. Andersen, MD PhD, Jurgen Finke, MD, Domenico Russo, MD, Jakob R Passweg, MD, Helene Schoemans, MD, Nadira Durakovic, MD PhD, Helene Labussiere, MD, Tobias Berg, MD, Dietger Niederwieser, MD, Wolfgang Bethge, MD, Nicola Mordini, MD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD PhD, Nicolaus Kroger, MD PhD, Silvia Montoto, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4657.
https://doi.org/10.1182/blood.V128.22.4657.4657
Published: 2016
Journal Articles

Implementation of NIH Criteria for Standardization of Chronic Graft-Versus-Host Disease in Croatia: Two-Year Experience

Lana Desnica, MD, Drazen Pulanic, MD PhD, Ranka Serventi Seiwerth, MD, Nikolina Matic, RN, Marinka Mravak Stipetic, DMD,PhD, Ervina Bilic, MD PhD, Romana Ceovic, MD PhD, Dina Ljubas Kelecic, mr. pharm., Ljubica Rajic, MD PhD, Ernest Bilic, MD PhD, Nadira Durakovic, MD PhD, Zinaida Peric, MD PhD, Tajana Klepac Pulanic, MD, Tamara Vukic, MD, Igor Petricek, MD PhD, Davorka Dusek, MD, Ines Bojanic, MD PhD, Ema Prenc, Mrs., Iva Ozana Prah, PhD, Magdalena Grce, PhD, Renata Zadro, MD PhD, Drago Batinic, MD PhD, Radovan Vrhovac, MD PhD, Steven Z. Pavletic, MD, Damir Nemet, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5580.
https://doi.org/10.1182/blood.V126.23.5580.5580
Published: 2015
Journal Articles

Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Wendy Ying, BA, Tracy T. Douglas, RN, MSN, Nadira Durakovic, MD, PhD, Sallie Brovitz-Palmer, RN, MSN, AOCNS, Lindsey Lombardi Thomas, PharmD, Richard J. Jones, Leo Luznik, Ephraim J. Fuchs
Journal: Blood
Blood (2011) 118 (21): 893.
https://doi.org/10.1182/blood.V118.21.893.893
Published: 2011
Journal Articles

Defining An Optimal Therapeutic Range for Busulfan (Bu) Administered with Pre-and Post-Transplant Cyclophosphamide (Cy) In HLA-Matched Related and Unrelated Bone Marrow Transplantation (BMT).

Lindsey R Lombardi, PharmD, Marianna Zahurak, M.S., Nadira Durakovic, MD, PhD, Jeanne Kowalski, PhD, Richard J. Jones, MD, Leo Luznik, MD
Journal: Blood
Blood (2010) 116 (21): 3474.
https://doi.org/10.1182/blood.V116.21.3474.3474
Published: 2010
Journal Articles

Efficacy and Safety of Colistin for the Treatment of Infections Caused by Multidrug-Resistant Isolates of Pseudomonas Aeruginosa Sensitive to Colistin in Patients with Haematological Malignancy; a Matched-Pair Analysis.

Nadira Durakovic, MD, Ana Boban, MD, Mirando Mrsic, MD, PhD, Dubravka Sertic, MD, Ranka Serventi Seiwerth, MD, Damir Nemet, MD, PhD, Boris Labar, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2283.
https://doi.org/10.1182/blood.V110.11.2283.2283
Published: 2007
Journal Articles

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse

Nadira Durakovic, Vedran Radojcic, Mario Skarica, Karl B. Bezak, Jonathan D. Powell, Ephraim J. Fuchs, Leo Luznik
Journal: Blood
Blood (2007) 109 (10): 4564–4574.
https://doi.org/10.1182/blood-2006-09-048124
Published: 2007
Includes: Supplemental data
Journal Articles

MHC Disparity, Dose of Irradiation and T Cells in the Graft Determine the Persistence of Residual Host DCs, Mostly Skin-Derived Langerhans Cells (LCs) That Are Targets of DLI-Mediated Alloresponse.

Nadira Durakovic, MD, Karl B. Bezak, BSc, Ephraim J. Fuchs, MD, Leo Luznik, MD
Journal: Blood
Blood (2004) 104 (11): 46.
https://doi.org/10.1182/blood.V104.11.46.46
Published: 2004
Journal Articles

Activation Status of Residual Host Dendritic Cells (DCs) but Not Their Number Governs Donor Lymphocyte Infusion (DLI)-Mediated Responses after Major Histocompatibility Complex (MHC)-Matched AlloBMT.

Nadira Durakovic, MD, Karl B. Bezak, Bsc, Ephraim J. Fuchs, MD, Luznik Leo, MD
Journal: Blood
Blood (2004) 104 (11): 3043.
https://doi.org/10.1182/blood.V104.11.3043.3043
Published: 2004